Trial Profile
Effects of zoledronic acid on renal insufficiency and hypocalcaemia in osteoporotic patients
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 06 Dec 2013
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Male osteoporosis; Postmenopausal osteoporosis
- Focus Adverse reactions
- 06 Dec 2013 New trial record
- 08 Oct 2013 Results presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.